Goldman Sachs’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2M | Sell |
350,520
-59,903
| -15% | -$3.45M | ﹤0.01% | 1765 |
|
|
2025
Q1 | $23.9M | Sell |
410,423
-139,892
| -25% | -$8.15M | ﹤0.01% | 1566 |
|
|
2024
Q4 | $44.3M | Buy |
550,315
+195,380
| +55% | +$15.7M | 0.01% | 1180 |
|
|
2024
Q3 | $28.4M | Buy |
354,935
+74,972
| +27% | +$6.01M | ﹤0.01% | 1463 |
|
|
2024
Q2 | $17.1M | Buy |
279,963
+130,846
| +88% | +$7.99M | ﹤0.01% | 1692 |
|
|
2024
Q1 | $7.37M | Buy |
149,117
+52,890
| +55% | +$2.61M | ﹤0.01% | 2292 |
|
|
2023
Q4 | $4.03M | Buy |
96,227
+5,365
| +6% | +$225K | ﹤0.01% | 2752 |
|
|
2023
Q3 | $2.98M | Buy |
90,862
+11,059
| +14% | +$363K | ﹤0.01% | 2831 |
|
|
2023
Q2 | $2.82M | Sell |
79,803
-84,821
| -52% | -$3M | ﹤0.01% | 2977 |
|
|
2023
Q1 | $4.68M | Buy |
164,624
+38,002
| +30% | +$1.08M | ﹤0.01% | 2594 |
|
|
2022
Q4 | $5.26M | Buy |
126,622
+57,379
| +83% | +$2.38M | ﹤0.01% | 2581 |
|
|
2022
Q3 | $2.87M | Buy |
69,243
+53,973
| +353% | +$2.24M | ﹤0.01% | 3078 |
|
|
2022
Q2 | $499K | Buy |
15,270
+4,566
| +43% | +$149K | ﹤0.01% | 4375 |
|
|
2022
Q1 | $375K | Buy |
+10,704
| New | +$375K | ﹤0.01% | 4758 |
|
|
2021
Q4 | – | Sell |
-57,803
| Closed | -$2.21M | – | 5639 |
|
|
2021
Q3 | $2.21M | Buy |
+57,803
| New | +$2.21M | ﹤0.01% | 3407 |
|